Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
: -,
Trial data show that patients who continue therapy tend to maintain their loss, while those who stop tend to regain a substantial portion which is why it is framed as a maintenance therapy, not a temporary course
That patent expired in Canada in January
MdBZR1 and MdBZR1-2like transcription factors improves salt tolerance by regulating gibberellin biosynthesis in apple
US$ 27.36
US$ 26.35
US$ 23.05
US$ 26.36
US$ 21.05
US$ 21.22
.png)
US$ 22.29
US$ 21.28
US$ 21.04
US$ 27.53
US$ 25.71
